- The Clinical Studies Group proactively engages with industrial partners in partnership with the NIHR CRN: Children industry team in developing true collaborative links in relation to the research and development of novel interventions and novel indications for existing interventions
- Important to the future work of the CSG, a panel of potential industrial partners interested in the future portfolio of the Paediatric Rheumatology CSG has been established and continues to develop. Any interested parties should approach the NIHR CRN: Children's industry team or alternatively the CSG Chair or one of the CSG Members
- In October 2011, the CSG hosted a very successful event entitled: "Supporting the development of the UK as a key location fpr clinical trials / studies in Paediatric Rheumatology". This was attended by senior representatives from Industry, NICE, MHRA, EMA, Research Networks, R&D, paediatric CRF, clinical investigators and consumers. The working group sessions were very lively and interactive, where challenges, solutions and strengths were discussed, extracting lots for common themes and open dialogue between the diverse functions. A significant key strength which the group highlighted which enables the UK to support development and delivery of clinical trials was the NIHR CRN: Children and the established Clinical Research Networks currently in place. Feedback from the attendees was very positive, the networks ability to gather together contributors from Europe, MHRA and NICE for the discussions was commended. Attendees were very enthused by the meeting and keen to take actions forward
Arthritis Research UK is developing the appropriate policies for managing such links.